92
Participants
Start Date
May 1, 2025
Primary Completion Date
May 1, 2027
Study Completion Date
October 1, 2027
Conversion to extended-release tacrolimus
Conversion from immediate-release tacrolimus (Prograf) to extended-release tacrolimus (Envarsus XR) as a part of the maintenance immunosuppressive treatment
Maintenance of immediate-release tacrolimus
Continuing immediate-release tacrolimus (Prograf) as a part of the maintenance immunosuppressive treatment
MGH Kidney Transplant Clinic, Boston
Collaborators (1)
Veloxis Pharmaceuticals
INDUSTRY
Massachusetts General Hospital
OTHER